Clinical Trial Update: The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial is evaluating the safety and efficacy of RAK Cell Therapy in late-stage gastric cancer. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• RAK Cell Therapy

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Gastric (Stomach) Cancer, Biological Therapy | Phase 2 | Status: RECRUITING